Here is What Institutional Investors Think About Gilead Sciences Inc (NASDAQ:GILD)

Mae Love
January 13, 2018

The institutional investor held 44,965 shares of the health care company at the end of 2017Q3, valued at $3.64M, up from 28,872 at the end of the previous reported quarter.

The counter witnessed a trading volume of 3.8 million shares versus an average volume of 2.29 million shares during last trading session. Dodge Cox reported 9.91 million shares.

LLC grew its position in shares of Gilead Sciences, Inc. It has underperformed by 38.50% the S&P500.

Andrew Sandler increased its stake in Live Nation Entertainment In (LYV) by 69.7% based on its latest 2017Q3 regulatory filing with the SEC. Penserra Capital Management LLC now owns 1,296 shares of the biopharmaceutical company's stock worth $102,000 after buying an additional 774 shares during the last quarter. Jacobs Levy Equity Management Inc who had been investing in Asbury Automotive Group Inc for a number of months, seems to be less bullish one the $1.57B market cap company. The stock increased 3.31% or $0.55 during the last trading session, reaching $17.15. About 78,481 shares traded. Northern Trust Corporation (NASDAQ:NTRS) has risen 22.45% since January 11, 2017 and is uptrending. It has underperformed by 0.20% the S&P500. About 5.74M shares traded. (NASDAQ:GILD) was sold by Alton Gregg H on Monday, October 2. Meyers James R also sold $4.99M worth of Gilead Sciences, Inc. (NASDAQ:GILD) sales have annually surged 29.40% on average, however its earnings per share growth remained at 41.20%.

Harvey Capital Management Inc, which manages about $386.73 million and $247.86 million US Long portfolio, upped its stake in Ulta Beauty Inc Com (NASDAQ:ULTA) by 2,000 shares to 4,700 shares, valued at $1.06M in 2017Q3, according to the filing. (NASDAQ:GILD) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The biopharmaceutical company reported $2.27 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.13 by $0.14. During the same quarter in the previous year, the firm posted $2.75 EPS. equities analysts forecast that Gilead Sciences, Inc. will post 8.53 earnings per share for the current year. Wall Street is only getting more bullish on the stock, with 14 of analysts who cover GILD having a buy-equivalent rating. Therefore 60% are positive.

Shares of Gilead Sciences, Inc.

Share Activity Lifted (-1.61%) for Oasis Petroleum Inc (OAS) in Session
Taking current value along prior value is a smoothing technique similar to that used in calculating an exponential moving average. To measure price-variation, we found OAS's volatility during a week at 3.95% and during a month it has been found around 4.17%.

Governor's office: Zinke reconsiders drilling off Oregon Coast
But Secretary Zinke's decision to take Florida off the table "should have his lawyers cringing", Hayes said . Oil platform used for offshore drilling .

Donald Trump doctor: Who is conducting US President's medical exam?
The White House says the 71-year-old president's exam will not include a psychiatric evaluation. Mr Trump launched a re-election committee within weeks of taking office in January 2017.

TRADEMARK VIOLATION NOTICE: "Vicus Capital Boosts Stake in Gilead Sciences, Inc". Maxim Group maintained the shares of GILD in report on Tuesday, May 30 with "Hold" rating. The company presently has a consensus rating of "Buy" and a consensus target price of $85.03. Leerink Swann maintained the stock with "Market Perform" rating in Thursday, October 5 report. As per Monday, June 12, the company rating was maintained by Jefferies. The stock has "Neutral" rating by Bank of America on Wednesday, September 30. The company was initiated on Thursday, August 31 by William Blair. The firm has "Outperform" rating given on Thursday, January 21 by RBC Capital Markets. The firm has "Buy" rating by Singular Research given on Monday, December 7. (NASDAQ:AAPL) rating on Tuesday, September 19. The company was maintained on Monday, July 24 by J.P. Morgan.

Investors sentiment decreased to 0.98 in 2017 Q3. Its down 0.20, from 1.17 in 2017Q2. Sold All: 96 Reduced: 488 Increased: 474 New Position: 127. The firm owned 11,496 shares of the biopharmaceutical company's stock after purchasing an additional 2,751 shares during the quarter. Sunbelt Securities invested in 0.61% or 7,150 shares. Mondrian Invest Prns holds 1.59% or 772,020 shares in its portfolio. First Heartland Consultants Incorporated stated it has 0.18% in Gilead Sciences, Inc. Piper Jaffray maintained the shares of GILD in report on Tuesday, July 25 with "Buy" rating. Dowling & Yahnke Llc holds 0.39% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) has "Outperform" rating given on Wednesday, January 20 by Credit Suisse. Ubs Oconnor Ltd Liability Corp invested in 23,424 shares. Employees Retirement Systems Of Ohio reported 0.02% stake. Manning And Napier Ltd Liability holds 189,381 shares. (NASDAQ:GILD). Windward Cap Mngmt Comm Ca invested in 0.54% or 40,775 shares.

Gilead Sciences Inc. (NASDAQ:GILD) gross margin percentage stands at 84.8% while its operating margin for the past trailing twelve month is 57.8 percent and its overall profit margin (ttm) is 42.2 Percent. (NASDAQ:GILD). Steinberg Global Asset holds 0.13% or 10,617 shares. Shareholders of record on Friday, December 15th were given a $0.52 dividend. Fairfield Bush &, a Connecticut-based fund reported 5,715 shares. Therefore 60% are positive. Apple Inc. had 344 analyst reports since July 21, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the stock with "Buy" rating in Friday, September 1 report.

Waking on tracing line of previous stocks, Baidu, Inc. (NYSE:LYV) has "Buy" rating given on Wednesday, August 9 by Macquarie Research. Bank of America downgraded Asbury Automotive Group, Inc.

Investors sentiment increased to 1.03 in Q3 2017. Its the same as in 2017Q2. 130,443 were accumulated by Goldman Sachs Grp Inc Inc. Mariner Wealth Ltd Liability invested in 0.05% or 11,710 shares. (NYSE:TOWR) for 275 shares. Zeke Cap Ltd owns 23,972 shares or 0.27% of their United States portfolio. Michigan-based Plante Moran Financial Advsr Ltd Llc has invested 0.16% in General Dynamics Corporation (NYSE:GD). United Services Automobile Association reported 75,580 shares. Berkshire Money Inc holds 1,485 shares or 0.07% of its portfolio. Ariel Investments Ltd Limited Liability Company holds 2.17M shares. (NYSE:GTN). Prudential Finance has invested 0.01% of its portfolio in Gray Television, Inc. (NASDAQ:AAPL). Cibc Asset Management holds 0.68% in Apple Inc. (NYSE:ABG) for 6,000 shares. Griffin Asset Mgmt has invested 0.39% in Gilead Sciences, Inc.

Other reports by

Discuss This Article